Potential effect of insulin resistance and cardiovascular risk factors on metabolic syndrome in subjects with normal fasting plasma glucose levels

被引:0
|
作者
Jeong, Dong Wook [1 ,2 ]
Lee, Jeong Gyu [1 ,2 ]
Lee, Sangyeoup [1 ,2 ,3 ]
Kim, Yun Jin [1 ,2 ]
Bae, Jae Ho [4 ]
Kim, Dong Hee [5 ]
Yi, Yu Hyeon [1 ,2 ]
Cho, Young Hye [1 ,2 ]
Chae, Uisoo
机构
[1] Pusan Natl Univ, Sch Med, Pusan Natl Univ Hosp, Ctr Obes Nutr & Metab,Dept Family Med, Pusan 602739, South Korea
[2] Pusan Natl Univ, Med Res Inst, Pusan Natl Univ Hosp, Sch Med, Pusan 602739, South Korea
[3] Pusan Natl Univ, Sch Med, Med Educ Unit, Pusan 602739, South Korea
[4] Pusan Natl Univ, Sch Med, Dept Biochem, Pusan 602739, South Korea
[5] Pusan Natl Univ, Coll Nursing, Pusan 602739, South Korea
关键词
Blood glucose; Metabolic syndrome; Insulin resistance; Cholesterol; Glucose intolerance; HOMEOSTASIS MODEL ASSESSMENT; CORONARY-HEART-DISEASE; CHOLESTEROL; SENSITIVITY; DIAGNOSIS; CRITERIA; HYPERGLYCEMIA; PREDICTION; TOLERANCE; INDEX;
D O I
10.1007/s13410-012-0069-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of metabolic syndrome has progressively increased with increasing fasting plasma glucose (FPG) levels. This study aimed to investigate the influence of insulin resistance and cardiovascular risk factors on metabolic syndrome in individuals with normal FPG. Study subjects with FPG levels below 100 mg/dL were divided into 5 groups depending on the exact FPG levels. We then evaluated the association of metabolic syndrome with insulin resistance and total cholesterol/ high density lipoprotein-cholesterol ratio (TC/HDL ratio). The odds ratio of insulin resistance in the level of HOMA-IR above 2.34 group [3.483(95 % CI, 1.110 similar to aEuro parts per thousand 10.932)] was significantly increased in the group of FPG level from 93 mg/dL to 99 mg/dL compared to the group below 80 mg/dL. The odds ratio of metabolic syndrome in the group of FPG level from 89 mg/dL to 92 mg/dL [2.459, (95%CI, 1.275 similar to aEuro parts per thousand 4.741)] and 93 mg/dL to 99 mg/dL [2.079, (95%CI, 1.052 similar to aEuro parts per thousand 4.110)] was significantly increased compared to the group below 80 mg/dL after adjusting age, sex, smoking status, physical activity, heavy drinking, TC/HDL ratio. Higher FPG levels within the normoglycemic range may constitute a risk of insulin resistance and is associated more strongly with the risks of metabolic syndrome.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 50 条
  • [31] Insulin resistance and fasting hyperinsulinemia are risk factors for new cardiovascular events in patients with prior coronary artery disease and normal glucose tolerance
    Yanase, M
    Takatsu, F
    Tagawa, T
    Kato, T
    Arai, K
    Koyasu, M
    Horibe, H
    Nomoto, S
    Takemoto, K
    Shimizu, S
    Watarai, M
    CIRCULATION JOURNAL, 2004, 68 (01) : 47 - 52
  • [32] Plasma Betatrophin Levels of Subjects Classified with Normal, Impaired, and Diabetic Glucose Tolerance, and Subjects with Impaired Fasting Glucose
    Ozyazgan, Sibel
    Onal, Burak
    Kurtulus, Eda Merve
    Uzun, Hafize
    Akkan, Gokhan
    Konukoglu, Dildar
    HORMONE AND METABOLIC RESEARCH, 2017, 49 (06) : 434 - 439
  • [33] Cardiovascular risk in subjects with high probability of metabolic syndrome and insulin resistance: DESIRE study.
    Goday, A.
    Gabriel, R.
    Ascaso, J. F.
    Franch, J.
    Ortega, R.
    Martinez, O.
    Lerones, N.
    REVISTA CLINICA ESPANOLA, 2008, 208 (08): : 377 - 385
  • [34] Obstructive sleep apnea impairs insulin resistance in metabolic syndrome patients with normal levels of glucose
    Cepeda, Felipe Xerez
    Rodrigues, Sara
    Dutra-Marques, Akothirene C. B.
    Carvalho, Jefferson Cabral
    Toschi-Dias, Edgar
    Jordao, Camila Paixao
    Rondon, Maria Urbana
    Alves, Maria Janieire N. N.
    Lorenzi-Filho, Geraldo
    Trombetta, Ivani Credidio
    FASEB JOURNAL, 2016, 30
  • [35] Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold
    Andreozzi, Francesco
    Succurro, Elena
    Mancuso, Maria Rosaria
    Perticone, Maria
    Sciacqua, Angela
    Perticone, Francesco
    Sesti, Giorgio
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2007, 23 (07) : 547 - 550
  • [36] Intense nonpharmacological intervention in subjects with multiple cardiovascular risk factors: Decreased fasting insulin levels but only a minor effect on plasma plasminogen activator inhibitor activity
    Lindahl, B
    Nilsson, TK
    Asplund, K
    Hallmans, G
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (04): : 384 - 390
  • [37] Fasting blood glucose and Risk of insulin resistance in Polycystic Ovary Syndrome
    Lerchbaumer, Barbara
    Wehr, Elisabeth
    Schweighofer, Natascha
    Pieber, Barbara
    Obermayer-Pietsch, Barbara
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (15-16) : A18 - A18
  • [38] Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucose
    Ford, ES
    Abbasi, F
    Reaven, GM
    ATHEROSCLEROSIS, 2005, 181 (01) : 143 - 148
  • [39] Effect of Orlistat on Plasma Leptin Levels and Risk Factors for the Metabolic Syndrome
    Dimitrov, Dimiter
    Bohchelian, Hripsime
    Koeva, Lidia
    METABOLIC SYNDROME AND RELATED DISORDERS, 2005, 3 (02) : 122 - 129
  • [40] Insulin resistance and cardiovascular disease risk factors in subjects with prehypertension
    Knobler, Hilla
    Abbasi, Fahim
    Lamendola, Cindy
    Reaven, Gerald M.
    DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (01): : 43 - 46